Clinical Trials Browser

INDUSTRY × CP protocol × Dermatologic × Clear all

NCT06008106 2024-06-28

Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

Phase 3 Recruiting

Melanoma

NCT00111007 2014-10-31

A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

Phase 3 Completed

270 enrolled 15 charts

Melanoma